Pfreundschuh Peter P.
SEC-identified person · CIK 1585839 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Y-Mabs Therapeutics, Inc. YMAB | EVP, CFO and Treasurer | filed 2024 - 2025 |
| Voyager Therapeutics, Inc. VYGR | Chief Financial Officer | filed 2022 - 2024 |
| Korro Bio, Inc. KRRO | Chief Financial Officer | filed 2020 - 2022 |
| Urogen Pharma Ltd. URGN | Chief Financial Officer | filed 2019 - 2020 |
| Sucampo Pharmaceuticals, Inc. SCMP | CFO | filed 2017 - 2018 |
| Immunomedics INC IMMU | Chief Financial Officer | filed 2013 - 2015 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.